MRNA

NASDAQ · Biotechnology

Moderna Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$54.32

-1.94 (-3.44%)

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 4 13%

Hold 19 63%

Sell 7 23%

Price Target

Analyst Price Target +175.1% upside

Low Target $89.97

Average Target $149.45

High Target $212.09

Current Price $54.32

Current
$54.32

Target
$149.45

$89.97 $149.45 avg $212.09

Scenario Analysis

Bear Case

$89.97

65.6%

Low target

Base Case

$149.45

+175.1%

Avg target

Bull Case

$212.09

+290.4%

High target

Risk/Reward

4.4x

Highly favorable

Price in Context

52-Week High

$85.60

-36.5% from high

52-Week Low

$22.28

+143.8% from low

50-Day SMA

$37.98

+43.0% vs SMA

200-Day SMA

$29.64

+83.3% vs SMA

RSI (14)

57.2

Neutral

Target vs 52W High

$149.45

+74.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%